V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10435766 | 10057418 | null | null | Palliative (P) | 2022-02-24 | 2022-03-27 | null | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101165781 |
| 10435795 | 10057419 | 1.67 | 77.8 | null | 2017-02-21 | 2017-03-02 | Cisplatin + Etoposide po&iv 3 day | 02 | null | PEMBROLIZUMAB + PEMETREXED | 100345746 |
| 10435928 | 10057420 | 1.71 | 84.2 | Palliative (P) | 2019-10-11 | 2019-10-18 | LEAM | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101609344 |
| 10436743 | 10057428 | 0 | 81.2 | null | 2021-01-28 | 2021-03-22 | null | null | null | VISMODEGIB | 101524307 |
| 10436800 | 10057429 | 1.53 | 56.5 | Disease modification (D) | 2017-12-23 | 2018-01-30 | Capecitabine (14 days)+Carboplatin | 02 | null | RUCAPARIB | 101460756 |
| 10436809 | 10057431 | 1.68 | 67.7 | Palliative (P) | 2020-01-15 | 2020-02-05 | null | 02 | N | MYELOMA XI TRIAL | 100447395 |
| 10436827 | 10057432 | 1.67 | 47 | Curative (C) | 2019-12-05 | 2019-12-16 | null | 02 | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 100696615 |
| 10436872 | 10057433 | null | null | null | 2017-02-05 | 2022-02-12 | CISPLATIN + FLUOROURACIL | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100898193 |
| 10437070 | 10057434 | 1.68 | 110.6 | null | 2020-09-19 | 2022-04-20 | TOPOTECAN | 02 | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100963505 |
| 10437192 | 10057437 | 1.61 | 62.7 | Palliative (P) | 2017-09-13 | 2017-09-14 | ALL UKALL60+ TRIAL | 02 | N | PAZOPANIB | 100214368 |
| 10437365 | 10057439 | 1.71 | 0 | null | 2018-07-21 | 2018-07-21 | Fulvestrant + Palbociclib | N | null | PENTOSTATIN | 101437045 |
| 10437439 | 10057440 | 1.71 | 74.4 | Palliative (P) | 2019-12-25 | 2019-12-28 | null | 02 | N | AML18 TRIAL | 100583277 |
| 10437589 | 10057441 | 1.59 | 91 | null | 2018-08-13 | 2018-08-13 | Pemetrexed | 02 | null | OXALIPLATIN + MDG | 100680739 |
| 10437652 | 10057442 | 0 | 78.5 | Palliative (P) | 2018-03-16 | 2018-10-24 | null | 02 | N | IXAZOMIB | 100786468 |
| 10437674 | 10057443 | 1.72 | 71.7 | null | null | 2018-03-20 | null | 01 | null | PEMETREXED | 101766499 |
| 10437947 | 10057446 | 1.72 | 70 | Palliative (P) | 2021-09-02 | 2021-09-05 | TRASTUZUMAB EMTANSINE | 02 | N | CARBOPLATIN + FLUOROURACIL | 100152227 |
| 10438141 | 10057447 | 1.75 | 86.4 | null | 2021-06-14 | 2021-06-14 | null | null | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101511436 |
| 10438175 | 10057448 | 1.77 | 51.7 | null | 2020-02-10 | 2020-02-11 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 100088426 |
| 10438188 | 10057449 | 1.68 | 53.6 | Adjuvant (A) | 2021-10-29 | 2021-10-29 | Topotecan (intravenous) | 02 | N | CARMUSTINE + THIOTEPA | 100720749 |
| 10438314 | 10057450 | 1.57 | 89.4 | Disease modification (D) | 2019-10-27 | 2020-04-09 | CHLORAMBUCIL + DEXAMETHASONE + DEXAMETHASONE + ETOPOSIDE | 02 | N | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100958475 |
| 10438319 | 10057451 | 1.67 | 59.4 | 03 | 2020-01-06 | 2020-03-29 | EVEROLIMUS | N | N | CARBOPLATIN + FLUOROURACIL | 100823772 |
| 10438324 | 10057452 | 0 | 0 | null | 2020-07-13 | 2020-08-27 | ANAGRELIDE | 02 | null | BLEOMYCIN | 101721919 |
| 10438328 | 10057453 | 1.77 | 0 | null | 2019-08-24 | 2019-09-24 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | N | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100496099 |
| 10438624 | 10057455 | 1.93 | 71.6 | Palliative (P) | 2019-12-13 | 2019-12-17 | ECarboX | 02 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 100580316 |
| 10438757 | 10057457 | null | null | Palliative (P) | null | 2019-05-29 | null | 02 | N | DASATINIB | 101119060 |
| 10439142 | 10057461 | 1.89 | 96.1 | Curative (C) | 2020-10-07 | 2020-10-07 | GEMCITABINE + RT | 02 | Y | BUSULPHAN | 100337421 |
| 10439306 | 10057462 | 1.59 | 52.2 | null | null | 2018-09-03 | null | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 101529428 |
| 10439350 | 10057463 | 1.75 | 78.15 | Curative (C) | 2020-02-27 | 2020-02-27 | null | 01 | N | CARMUSTINE + THIOTEPA | 101300168 |
| 10439361 | 10057464 | 1.5 | 0 | null | 2019-11-16 | 2019-11-19 | Obinutuzumab +CVP | 02 | null | OBINUTUZUMAB | 100211794 |
| 10439777 | 10057466 | 1.66 | 71.8 | null | 2020-04-18 | 2020-12-15 | Irinotecan | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101179068 |
| 10439817 | 10057467 | 1.75 | 106.3 | Curative (C) | 2020-02-11 | 2020-02-26 | R Chlorambucil | 02 | null | FLAIR TRIAL | 100630419 |
| 10440042 | 10057470 | null | null | null | 2019-07-07 | 2019-07-15 | Doxorubicin + Ifosfamide | Y | null | CISPLATIN + CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100571922 |
| 10440163 | 10057473 | 0 | 56.4 | Palliative (P) | 2019-05-28 | 2019-06-11 | null | 02 | N | BORTEZOMIB + MELPHALAN | 100235272 |
| 10440226 | 10057474 | 1.75 | 94.2 | null | 2019-11-05 | 2020-02-17 | GEFITINIB | 02 | null | LENVATINIB | 100812512 |
| 10440345 | 10057475 | 1.66 | 64.9 | Adjuvant (A) | 2018-01-31 | 2018-10-03 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | GEFITINIB | 101581018 |
| 10440452 | 10057476 | 1.56 | 64.2 | null | 2019-12-09 | 2019-12-19 | null | null | null | VINCRISTINE | 100945468 |
| 10440586 | 10057477 | 1.68 | 69.7 | null | 2020-06-03 | 2020-06-18 | LENVATINIB | null | N | CARBOPLATIN + FLUOROURACIL | 100119563 |
| 10440602 | 10057478 | 1.64 | 62.1 | Curative (C) | 2022-01-02 | 2022-01-02 | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 02 | null | OXALIPLATIN + MDG | 101184031 |
| 10440649 | 10057479 | 1.53 | 51.7 | null | 2020-04-05 | 2020-04-07 | ETOPOSIDE | 01 | null | CISPLATIN + PEMETREXED | 100497212 |
| 10440797 | 10057480 | 1.7 | 91.6 | Palliative (P) | 2018-11-10 | 2019-08-05 | PCV | 02 | N | BLEOMYCIN | 100552559 |
| 10440897 | 10057481 | 0 | 57 | null | 2019-03-03 | 2019-03-27 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 02 | null | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 101477320 |
| 10440928 | 10057483 | 0 | 106.5 | 03 | null | 2020-03-02 | Lomustine | N | N | CHLORAMBUCIL + ETOPOSIDE | 101293525 |
| 10440931 | 10057484 | 1.67 | 50.6 | null | 2022-04-03 | 2022-04-03 | Bendamustine + Obinutuzumab | 02 | null | OCTREOTIDE | 101588954 |
| 10441223 | 10057487 | 0 | 60.2 | null | 2019-01-16 | 2019-02-23 | Cisplatin + Radiotherapy | 02 | null | CYTARABINE HIGH DOSE | 101682008 |
| 10441605 | 10057489 | 1.5 | 77.8 | null | 2018-05-23 | 2018-06-28 | IDELALISIB + RITUXIMAB | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100961103 |
| 10441650 | 10057490 | 1.53 | 84.5 | null | 2018-10-20 | 2018-10-20 | Everolimus 10mg | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100413108 |
| 10441740 | 10057491 | 1.6 | 76.2 | null | 2018-12-21 | 2018-12-29 | null | null | null | OBINUTUZUMAB | 100490571 |
| 10442009 | 10057492 | 1.71 | 129 | Curative (C) | 2019-10-08 | 2019-12-19 | Letrozole + Ribociclib | 02 | N | PENTOSTATIN | 100067737 |
| 10442117 | 10057494 | 164 | 96.1 | Palliative (P) | 2021-05-18 | 2021-05-18 | BOSUTINIB | 02 | null | OBINUTUZUMAB + VENETOCLAX | 101357773 |
| 10442148 | 10057495 | 1.7 | 80.8 | Curative (C) | null | 2019-09-07 | STAMPEDE TRIAL | 02 | N | EVEROLIMUS | 100905143 |